Approval · Notice of Compliance 16632 · 2015
PROPOFOL INJECTION: Notice of Compliance 16632
Issued February 23, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16632
- Date
- February 23, 2015
- Company
- Fresenius Kabi Canada LtdToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Anaesthetic / sedative
- Canadian reference product
- DIPPRIVAN (Astrazeneca Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROPOFOL INJECTION | 02437643 | Marketed |
Medicinal ingredients
- PROPOFOL 10 MG per ML